Literature DB >> 24900881

Kinesin spindle protein inhibitors with diaryl amine scaffolds: crystal packing analysis for improved aqueous solubility.

Tomoki Takeuchi1, Shinya Oishi1, Masato Kaneda1, Hiroaki Ohno1, Shinya Nakamura2, Isao Nakanishi2, Masayoshi Yamane3, Jun-Ichi Sawada3, Akira Asai3, Nobutaka Fujii1.   

Abstract

Diaryl amine derivatives have been designed and synthesized as novel kinesin spindle protein (KSP) inhibitors based on planar carbazole-type KSP inhibitors with poor aqueous solubility. The new generation of inhibitors was found to show comparable inhibitory activity and high selectivity for KSP, and this was accompanied with improved solubility. Kinetic analysis and molecular modeling studies suggested that these inhibitors work in an ATP-competitive manner via binding to the secondary allosteric site formed by α4 and α6 helices of KSP. Comparative structural investigations on a series of compounds revealed that the higher solubility of diaryl amine-type inhibitors was attributed to fewer van der Waals interactions in the crystal packing and the hydrogen-bond acceptor nitrogen of the aniline moiety for favorable solvation.

Entities:  

Keywords:  Aqueous solubility; crystal packing; diphenylamine; kinesin spindle protein

Year:  2014        PMID: 24900881      PMCID: PMC4027754          DOI: 10.1021/ml500016j

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  21 in total

1.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.

Authors:  T U Mayer; T M Kapoor; S J Haggarty; R W King; S L Schreiber; T J Mitchison
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

Review 2.  Targeting the kinesin spindle protein: basic principles and clinical implications.

Authors:  Vasiliki Sarli; Athanassios Giannis
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

3.  Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.

Authors:  Kenji Matsuno; Jun-ichi Sawada; Mina Sugimoto; Naohisa Ogo; Akira Asai
Journal:  Bioorg Med Chem Lett       Date:  2009-01-11       Impact factor: 2.823

4.  A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor.

Authors:  Nai-Dong Xing; Sen-Tai Ding; Ryoichi Saito; Koji Nishizawa; Takashi Kobayashi; Takahiro Inoue; Shinya Oishi; Nobutaka Fujii; Jia-Jv Lv; Osamu Ogawa; Hiroyuki Nishiyama
Journal:  Asian J Androl       Date:  2011-02-07       Impact factor: 3.285

5.  Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.

Authors:  Tomoki Takeuchi; Shinya Oishi; Toshiaki Watanabe; Hiroaki Ohno; Jun-ichi Sawada; Kenji Matsuno; Akira Asai; Naoya Asada; Kazuo Kitaura; Nobutaka Fujii
Journal:  J Med Chem       Date:  2011-06-07       Impact factor: 7.446

Review 6.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

7.  Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.

Authors:  James S Scott; Alan M Birch; Katy J Brocklehurst; Anders Broo; Hayley S Brown; Roger J Butlin; David S Clarke; Ojvind Davidsson; Anne Ertan; Kristin Goldberg; Sam D Groombridge; Julian A Hudson; David Laber; Andrew G Leach; Philip A Macfaul; Darren McKerrecher; Adrian Pickup; Paul Schofield; Per H Svensson; Pernilla Sörme; Joanne Teague
Journal:  J Med Chem       Date:  2012-05-17       Impact factor: 7.446

8.  A novel action of terpendole E on the motor activity of mitotic Kinesin Eg5.

Authors:  Junko Nakazawa; Junichiro Yajima; Takeo Usui; Masashi Ueki; Akira Takatsuki; Masaya Imoto; Yoko Y Toyoshima; Hiroyuki Osada
Journal:  Chem Biol       Date:  2003-02

9.  A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor.

Authors:  Sentai Ding; Koji Nishizawa; Takashi Kobayashi; Shinya Oishi; Jiajv Lv; Nobutaka Fujii; Osamu Ogawa; Hiroyuki Nishiyama
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

10.  Antitumor activity of a kinesin inhibitor.

Authors:  Roman Sakowicz; Jeffrey T Finer; Christophe Beraud; Anne Crompton; Evan Lewis; Alex Fritsch; Yan Lee; John Mak; Robert Moody; Rebecca Turincio; John C Chabala; Paul Gonzales; Stephanie Roth; Steve Weitman; Kenneth W Wood
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

View more
  3 in total

1.  Unconventional N-H…N Hydrogen Bonds Involving Proline Backbone Nitrogen in Protein Structures.

Authors:  R N V Krishna Deepak; Ramasubbu Sankararamakrishnan
Journal:  Biophys J       Date:  2016-05-10       Impact factor: 4.033

2.  Design, synthesis and biological evaluation of novel Schiff base-bridged tetrahydroprotoberberine triazoles as a new type of potential antimicrobial agents.

Authors:  Jun-Rong Duan; Han-Bo Liu; Ponmani Jeyakkumar; Lavanya Gopala; Shuo Li; Rong-Xia Geng; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

Review 3.  Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy.

Authors:  Stephanie M Myers; Ian Collins
Journal:  Future Med Chem       Date:  2016-03-15       Impact factor: 3.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.